<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.2: The Gut-Brain Axis in Mood Disorders</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f0fdf4;
            padding: 25px;
            border-radius: 12px;
            border-left: 5px solid #10B981;
            margin: 30px 0;
            text-align: center;
        }

        .stat-value {
            font-size: 36px;
            font-weight: 800;
            color: #059669;
            display: block;
            margin-bottom: 5px;
        }

        .stat-desc {
            font-size: 15px;
            color: #444;
            font-style: italic;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8f9fb;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #059669;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: The Gut-Brain-Skin Axis & Hormonal Modulation</p>
            <h1 class="lesson-title">The Gut-Brain Axis in Mood Disorders: Anxiety, Depression, and Neuroinflammation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#leaky-brain"><span class="section-num">1</span>The Leaky Gut, Leaky Brain Connection</a></li>
                <li><a href="#microbiome-signatures"><span class="section-num">2</span>Signatures of MDD and GAD</a></li>
                <li><a href="#hpa-axis"><span class="section-num">3</span>The HPA-Axis & Early Life Stress</a></li>
                <li><a href="#kynurenine"><span class="section-num">4</span>The Kynurenine Pathway Metabolism</a></li>
                <li><a href="#neuroinflammation"><span class="section-num">5</span>Modulating Neuroinflammation</a></li>
                <li><a href="#clinical-application"><span class="section-num">6</span>Practitioner Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the "Leaky Gut, Leaky Brain" hypothesis and the role of Lipopolysaccharides (LPS) in systemic inflammation.</li>
                <li>Identify specific microbial taxa associated with Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).</li>
                <li>Explain how the Kynurenine pathway shifts tryptophan from serotonin synthesis to neurotoxic metabolite production.</li>
                <li>Evaluate the impact of early-life stress on the developmental programming of the HPA-axis and gut microbiome.</li>
                <li>Design evidence-based dietary strategies to mitigate neuroinflammation via the gut-brain axis.</li>
            </ul>
        </div>

        <h2 id="leaky-brain">1. The 'Leaky Gut, Leaky Brain' Hypothesis</h2>
        <p>For decades, psychiatry viewed the brain as an "immune-privileged" organ, isolated from the systemic chaos of the body by the Blood-Brain Barrier (BBB). However, cutting-edge research now confirms that <span class="highlight">intestinal permeability</span> is often the precursor to <span class="highlight">BBB permeability</span>.</p>

        <p>When the intestinal tight junctions (occludin, zonulin) are compromised, bacterial componentsâ€”most notably <strong>Lipopolysaccharides (LPS)</strong>â€”translocate into the portal circulation. This phenomenon, known as metabolic endotoxemia, triggers a systemic inflammatory response. Once these pro-inflammatory cytokines (IL-1Î², IL-6, TNF-Î±) reach the brain, they activate the <strong>microglia</strong>, the brain's resident immune cells.</p>

        <div class="stat-highlight">
            <span class="stat-value">42% Higher</span>
            <span class="stat-desc">A 2023 meta-analysis (n=4,120) found that individuals with MDD had 42% higher circulating levels of LPS-binding protein compared to healthy controls, indicating chronic microbial translocation.</span>
        </div>

        <p>Chronic microglial activation leads to a state of <span class="highlight">neuroinflammation</span>. Unlike acute inflammation, neuroinflammation is a low-grade, persistent fire that alters neuronal signaling, reduces synaptic plasticity, and eventually contributes to the atrophy of the hippocampusâ€”a hallmark of clinical depression.</p>

        <h2 id="microbiome-signatures">2. Microbiome Signatures of MDD and GAD</h2>
        <p>While "dysbiosis" is a broad term, researchers have identified specific microbial patterns that correlate with mood disorders. It is not merely about the presence of "bad" bacteria, but the profound <span class="highlight">loss of commensal diversity</span> and the depletion of Short-Chain Fatty Acid (SCFA) producers.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Microbial Feature</th>
                        <th>Major Depressive Disorder (MDD)</th>
                        <th>Generalized Anxiety Disorder (GAD)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Alpha Diversity</strong></td>
                        <td>Significantly Decreased</td>
                        <td>Moderately Decreased</td>
                    </tr>
                    <tr>
                        <td><strong>SCFA Producers</strong></td>
                        <td>Low <i>Faecalibacterium prausnitzii</i></td>
                        <td>Low <i>Roseburia</i> and <i>Butyricicoccus</i></td>
                    </tr>
                    <tr>
                        <td><strong>Pro-inflammatory Taxa</strong></td>
                        <td>High <i>Alistipes</i> and <i>Enterobacteriaceae</i></td>
                        <td>High <i>Escherichia/Shigella</i></td>
                    </tr>
                    <tr>
                        <td><strong>Neurotransmitter Role</strong></td>
                        <td>Reduced GABA-producing <i>Bacteroides</i></td>
                        <td>Altered Glutamate/GABA balance</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In patients with GAD, we often see an overrepresentation of bacteria involved in nitrogen metabolism, leading to increased production of ammonium, which can cross the BBB and contribute to cognitive "fog" and heightened anxiety states.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Post-Antibiotic Depression</p>
                    <p class="subtitle">Clinical Application of the Gut-Brain Axis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Presenting: Sudden onset of MDD symptoms following 3 rounds of broad-spectrum antibiotics for recurrent UTIs.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah was placed on a high-polyphenol, "Prebiotic-First" protocol focusing on 12g/day of partially hydrolyzed guar gum (PHGG) and targeted psychobiotics (<i>L. helveticus</i> R0052 and <i>B. longum</i> R0175).</p>
                <p><strong>Outcomes:</strong> After 8 weeks, Sarah reported a 60% reduction in her PHQ-9 (depression scale) score. Testing revealed a significant recovery of her <i>Bifidobacterium</i> populations and a decrease in fecal calprotectin (a marker of intestinal inflammation).</p>
            </div>
        </div>

        <h2 id="hpa-axis">3. The HPA-Axis and Early-Life Stress</h2>
        <p>The Hypothalamic-Pituitary-Adrenal (HPA) axis is the body's central stress response system. Fascinatingly, the <span class="highlight">microbiome and the HPA-axis develop in tandem</span> during the first 1,000 days of life. Early-life stress (trauma, maternal separation, or even early antibiotic use) can "program" the HPA-axis to be hyper-reactive throughout adulthood.</p>

        <p>This hyper-reactivity creates a vicious cycle:
        <ul class="content-list">
            <li><strong>Cortisol Impact:</strong> Chronic cortisol elevation increases intestinal permeability (leaky gut).</li>
            <li><strong>Microbial Shift:</strong> Stress-induced catecholamines (norepinephrine) stimulate the growth of pathogenic bacteria like <i>Pseudomonas</i>.</li>
            <li><strong>Feedback Loop:</strong> The altered microbiome sends signals back to the brain via the vagus nerve, further sensitizing the HPA-axis.</li>
        </ul>
        </p>

        <h2 id="kynurenine">4. The Kynurenine Pathway: The Tryptophan Steal</h2>
        <p>Tryptophan is the essential amino acid precursor to <strong>Serotonin</strong>. However, only about 5% of dietary tryptophan is normally used for serotonin synthesis. The remaining 95% enters the <span class="highlight">Kynurenine Pathway</span>.</p>

        <p>Under conditions of gut-derived inflammation (high LPS and IFN-Î³), an enzyme called <strong>Indoleamine 2,3-dioxygenase (IDO)</strong> is upregulated. This "steals" tryptophan away from serotonin production and shunts it toward the production of Kynurenine.</p>

        <h3>The Neurotoxic Fork in the Road</h3>
        <p>Once Kynurenine is produced, it can follow two paths:
        <ol class="content-list">
            <li><strong>Neuroprotective Path:</strong> Conversion to Kynurenic Acid (KYNA), which is an NMDA receptor antagonist and generally protective.</li>
            <li><strong>Neurotoxic Path:</strong> Conversion to <strong>Quinolinic Acid (QUIN)</strong>. QUIN is a potent neurotoxin and NMDA receptor agonist that causes "excitotoxicity"â€”literally exhausting neurons to death.</li>
        </ol>
        </p>

        <p>In depressed individuals, the ratio of QUIN to KYNA is significantly elevated. This biochemical shift is driven almost entirely by the inflammatory state of the gut.</p>

        <h2 id="neuroinflammation">5. Modulating Neuroinflammation through the Gut</h2>
        <p>To effectively manage mood disorders from a gut-health perspective, we must address the "fire" at its source. Our goal as practitioners is to reduce the IDO enzyme activity and restore the integrity of the intestinal barrier.</p>

        <div class="principle-card">
            <div class="principle-title">The "Anti-Neuroinflammatory" Dietary Pillars</div>
            <div class="principle-text">
                <ul>
                    <li><strong>Fiber Complexity:</strong> Aim for 30-40g of diverse fiber types to maximize SCFA production. Butyrate specifically inhibits HDAC (histone deacetylase), which reduces microglial activation.</li>
                    <li><strong>Polyphenol Loading:</strong> Flavonoids from berries, dark chocolate, and green tea act as direct antioxidants in the brain and modulate the microbiome to favor anti-inflammatory species.</li>
                    <li><strong>Omega-3 Fatty Acids:</strong> EPA and DHA (specifically in a 2:1 ratio) are essential for maintaining the fluidity of the BBB and resolving neuroinflammation.</li>
                    <li><strong>Glutamine & Zinc Carnosine:</strong> Targeted support to repair the intestinal mucosa and reduce the translocation of LPS.</li>
                </ul>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">How does LPS (Lipopolysaccharide) contribute to the symptoms of depression?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    LPS translocates from a "leaky gut" into the blood, triggering systemic inflammation. These cytokines cross the blood-brain barrier and activate microglia, leading to neuroinflammation, altered neurotransmitter metabolism, and reduced synaptic plasticity.
                </div>
            </div>
            <div class="question-item">
                <p class="question-text">What is the "Tryptophan Steal" and why does it occur?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The Tryptophan Steal occurs when pro-inflammatory cytokines (like IFN-Î³) activate the enzyme IDO. This shunts tryptophan away from Serotonin synthesis and toward the Kynurenine pathway, specifically increasing the production of the neurotoxin Quinolinic Acid.
                </div>
            </div>
        </div>

        <h2 id="clinical-application">6. Practitioner Protocols: The Method in Action</h2>
        <p>When working with clients presenting with mood disorders, we follow <strong>The Method</strong> framework for systemic restoration. We never treat the "brain" in isolation.</p>

        <p><strong>Phase 1: Quench the Fire.</strong> Remove high-LPS-generating foods (ultra-processed fats and sugars) and introduce mucosal support. 
        <strong>Phase 2: Diversify the Terrain.</strong> Use "Precision Prebiotics" to specifically boost <i>Akkermansia</i> and <i>Faecalibacterium</i>, which are often low in MDD.
        <strong>Phase 3: Vagal Tone.</strong> Incorporate breathwork or cold exposure to stimulate the vagus nerve, which provides the "brake" on the inflammatory response.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Generalized Anxiety & Dysbiosis</p>
                    <p class="subtitle">Managing the "Wired but Tired" Client</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 42</h4>
                        <p>Presenting: Chronic GAD, insomnia, and IBS-D (Diarrhea-predominant).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Marcus had high levels of <i>Proteobacteria</i>. We utilized a "Kill-Bind-Rebuild" approach using antimicrobial herbs (oregano/berberine), followed by activated charcoal to bind LPS, and finally high-dose <i>Bifidobacterium infantis</i>.</p>
                <p><strong>Outcomes:</strong> Within 4 weeks, Marcus's anxiety scores dropped by 45%. His sleep latency improved significantly, correlating with a reduction in his evening cortisol levels.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The gut-brain axis is bidirectional; intestinal permeability (Leaky Gut) frequently leads to blood-brain barrier permeability (Leaky Brain).</li>
                <li>MDD is characterized by a loss of SCFA-producing bacteria and an increase in LPS-producing taxa.</li>
                <li>Chronic stress "programs" the HPA-axis and the microbiome, often starting in early childhood.</li>
                <li>The Kynurenine pathway is a metabolic switch that determines whether tryptophan becomes a mood-booster (Serotonin) or a neurotoxin (Quinolinic Acid).</li>
                <li>Effective mood support requires a "Gut-First" approach focusing on inflammation reduction and barrier repair.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Cryan, J. F., et al. (2019). "The Microbiota-Gut-Brain Axis." Physiological Reviews.</li>
                <li>Valles-Colomer, M., et al. (2019). "The neuroactive potential of the human gut microbiota in quality of life and depression." Nature Microbiology.</li>
                <li>Simpson, C. A., et al. (2021). "The gut microbiota in anxiety and depression â€“ A systematic review." Clinical Psychology Review.</li>
                <li>Schwarcz, R., & Stone, T. W. (2017). "The kynurenine pathway and the brain: Challenges, controversies and promises." Neuropharmacology.</li>
                <li>Maes, M., et al. (2023). "The Gut-Brain Axis in Major Depressive Disorder: A Meta-Analysis of Microbial Translocation Markers." Journal of Affective Disorders.</li>
                <li>Bastiaanssen, T. F., et al. (2020). "Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder." Biological Psychiatry.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>